Michel Streuli
14Patents
4h-index
24Co-inventors
60Inventor score
Filing activity: Jan 5, 1990 → Dec 19, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6180849A | Trangenic mice with a disruption in the tiar gene | Chemistry; Metallurgy | 15 | Expired |
| US5298407A | DNA encoding a protein active in lymphocyte-mediated cytotoxicity | Chemistry; Metallurgy | 8 | Expired |
| US8460667B2 | EPHA2 receptor antagonist antibodies | Physics | 5 | Active |
| US5340935A | DNAS encoding proteins active in lymphocyte-medicated cytotoxicity | Chemistry; Metallurgy | 5 | Expired |
| US5079343A | Intracellular antigen found in subpopulation of CD8.sup.+ T lymphocytes and monoclonal antibody reactive with same | Chemistry; Metallurgy | 4 | Expired |
| US5994070A | Trio molecules and uses related thereto | Chemistry; Metallurgy | 3 | Expired |
| US8992912B2 | Methods of use for antibodies that specifically bind to the EphA2 receptor | Physics | 1 | Active |
| US10508148B2 | Anti-TREM2 antibodies and related methods | Physics | 0 | Active |
| US11572407B2 | Anti-MARCO antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11505602B2 | Anti-TREM2 antibodies and related methods | Physics | 0 | Active |
| US12428481B2 | Anti-TREM2 antibodies and related methods | Physics | 0 | Active |
| USRE47123E1 | EPHA2 receptor antagonist antibodies | General | 0 | Active |
| US12378311B2 | Anti-MARCO antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US5837811A | Proteins active in lymphocyte-mediated cytotoxicity | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.